ConductScience.org, home

Paper40950996

Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.

Wang H and 3 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report. Papers, record 40950996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40950996

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2025
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang HHuifang
2Huang YYiqi
3Jin FFeng
4Liu XXinxin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124670080Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.J Clin Endocrinol Metab2014https://conductscience.org/library/papers/24670080PubMed
21928065C1q nephropathy: a pediatric clinicopathologic study.Am J Kidney Dis1991https://conductscience.org/library/papers/1928065PubMed
340228233Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials.Clin J Am Soc Nephrol2025https://conductscience.org/library/papers/40228233PubMed
431333655Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection.Front Immunol2019https://conductscience.org/library/papers/31333655PubMed
533193097Use of Rituximab After Orbital Decompression Surgery in Two Grave's Ophthalmopathy Patients Progressing to Optic Neuropathy.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33193097PubMed
619656128Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.Am J Transplant2010https://conductscience.org/library/papers/19656128PubMed
724326785C1q nephropathy in children: clinical characteristics and outcome.Pediatr Nephrol2014https://conductscience.org/library/papers/24326785PubMed
819082635C1q nephropathy and minimal change nephrotic syndrome.Pediatr Nephrol2009https://conductscience.org/library/papers/19082635PubMed
912218324De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy?Nephron2002https://conductscience.org/library/papers/12218324PubMed
1029174175Imaging appearances of hepatic tuberculosis: experience with 12 patients.Clin Radiol2018https://conductscience.org/library/papers/29174175PubMed
1118650484Pathology, clinical presentations, and outcomes of C1q nephropathy.J Am Soc Nephrol2008https://conductscience.org/library/papers/18650484PubMed
1234670275High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.Blood Adv2022https://conductscience.org/library/papers/34670275PubMed
1331002691C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.PLoS One2019https://conductscience.org/library/papers/31002691PubMed
1433862010Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.J Allergy Clin Immunol2021https://conductscience.org/library/papers/33862010PubMed
1521378402Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Ann Rheum Dis2011https://conductscience.org/library/papers/21378402PubMed
1630646343Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.JAMA Netw Open2018https://conductscience.org/library/papers/30646343PubMed
1726742572Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients.Exp Clin Transplant2016https://conductscience.org/library/papers/26742572PubMed
1838222154Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study.Cureus2023https://conductscience.org/library/papers/38222154PubMed
1925943103A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection.BMC Infect Dis2015https://conductscience.org/library/papers/25943103PubMed
2026499189Hepatic tuberculosis: a multimodality imaging review.Insights Imaging2015https://conductscience.org/library/papers/26499189PubMed

See all 42 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42464147Hepatic and splenic tuberculosis following infliximab therapy for refractory ulcerative colitis: a case report and literature review.BMC Gastroenterol2026https://conductscience.org/library/papers/42464147

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40950996

GET https://conductscience.org/api/papers/v1/40950996/references?page=2